CN101230089A - Solid-phase synthesis of glycyl histidyl lycine - Google Patents
Solid-phase synthesis of glycyl histidyl lycine Download PDFInfo
- Publication number
- CN101230089A CN101230089A CNA200810043144XA CN200810043144A CN101230089A CN 101230089 A CN101230089 A CN 101230089A CN A200810043144X A CNA200810043144X A CN A200810043144XA CN 200810043144 A CN200810043144 A CN 200810043144A CN 101230089 A CN101230089 A CN 101230089A
- Authority
- CN
- China
- Prior art keywords
- methionin
- fmoc
- fluorenylmethyloxycarbonyl
- histidyl
- resin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Peptides Or Proteins (AREA)
Abstract
The invention relates to an amino acid synthetic method, in particular to a solid phase synthetic method of glycyl-histidyl-lysine. The invention mainly solves the technical problem that two basic amino acids are included in the molecule to result in the artificial synthesis to be difficult. During synthesis, Fmoc-Lys(BOC)-OH and Wang Resin are mixed according to the proportion, HOBT, DIC and DMAP are added into to be used as activating agent, DMF is taken as solvent and reacts in the oscillating way, and Fmoc-lys(Boc)-Wang Resin is obtained after the reaction product is filtered and washed; a Fmoc base group is removed from DMF solution added with hexahydropyridine, to obtain H-lys(Boc)Wang Resin; and then Fmoc-His(trt)-OH is added to obtain Fmoc-His(trt)-lys(Boc)Wang Resin through the acylating-aminating reaction; Fmoc is removed, and then glycin is added, and Fmoc-Gly-His(trt)-lys(Boc)Wang Resin is obtained through the acylating-aminating reaction; Fmoc is removed, and then TFA is added, after oscillation, the filter is performed, filtrate is taken to be washed and frozen out to obtain the end product.
Description
Technical field: the present invention relates to a seed amino acid synthetic method, particularly a kind of solid phase synthesis process of glycyl histidyl-Methionin.
Background technology: glycyl histidyl-Methionin (GHK) is at first to separate a kind of tripeptides obtain by people such as Pickart from human plasma in 1973.GHK can increase mouse normal liver cell survival rate and impel the growth of liver cancer cell, and stimulate the synthetic of these cell DNAs and RNA, therefore be called as pHGF.Current research shows that also GHK and GHK-Gu2+ (complex compound that GHK and bivalent cupric ion form) can impel neurocyte, the growth division and the differentiation of immunity-associated cell and messangial cell.Owing in the GHK molecule 2 basic aminoacidss are arranged, bring a lot of difficulties to synthetic.Traditional liquid-phase synthesis process synthesis cycle is long, and technology is loaded down with trivial details, pollutes greatly, has not more and more met present production requirement.
Summary of the invention: the solid phase synthesis process that the purpose of this invention is to provide a kind of glycyl histidyl-Methionin.Mainly solve and contain 2 basic aminoacidss in its molecule and cause synthetic difficult technologies problem.Technical scheme of the present invention is: a kind of solid phase synthesis process of glycyl histidyl-Methionin may further comprise the steps:
1, Fmoc-Lys (BOC)-OH and Wang Resin (king's resin) are mixed in proportion, add HOBT, DIC and DMAP as activator, make solvent 45 ℃~50 ℃ following oscillatory reactions with DMF, obtain Fmoc-lys (Boc)-Wang Resin behind the reaction product filtration washing;
2, with Fmoc-lys (Boc) the Wang Resin that obtains in the step 1, add in the DMF solution of hexahydropyridine, the Fmoc group is removed, obtain H-lys (Boc) Wang Resin; Add Fmoc-His (trt)-OH then, reaction obtains Fmoc-His (trt)-lys (Boc) Wang Resin through amidated;
3, the Fmoc with Fmoc-His (trt)-lys (Boc) Wang Resin of obtaining in the step 2 removes, and adds Fmoc-Gly-OH, obtains Fmoc-Gly-His (trt)-lys (Boc) Wang Resin by the amidated reaction;
4, get product in the step 3, remove Fmoc, add TFA, the vibration after-filtration is got filtrate washing freeze-drying and can be got H-Gly-His-Lys-OH.
Methionin is excessive 1.5~2 times in the step 1, and the oscillatory reaction time is 3~5 hours; The concentration of the DMF solution of hexahydropyridine is 10~30% in the step 2, and step 4 duration of oscillation is 1~3 hour.
Some abbreviations commonly used have following implication among the present invention:
Fmoc: fluorenylmethyloxycarbonyl
Wang Resin: king's resin
Boc: tertbutyloxycarbonyl
Fmoc-Lys (BOC)-OH: Methionin
The HOBt:1-hydroxybenzotriazole
DIC:N, N '-di-isopropyl carbimide
The DMAP:4-Dimethylamino pyridine
DMF:N, N '-dimethyl formamide
Trt: trityl
Lys: Methionin
His: Histidine
Gly: glycine
TFA: trifluoroacetic acid
Fmoc-lys (Boc)-Wang Resin: fluorenylmethyloxycarbonyl Methionin (tertbutyloxycarbonyl) king resin
H-lys (Boc) Wang Resin: Methionin (tertbutyloxycarbonyl) king resin
Fmoc-His (trt)-lys (Boc) Wang Resin: fluorenylmethyloxycarbonyl histidyl-(trityl) Methionin (tertbutyloxycarbonyl) king resin
Fmoc-His (trt)-OH: fluorenylmethyloxycarbonyl (trityl) Histidine
H-His (trt)-lys (Boc) Wang Resin: histidyl-(trityl) Methionin (tertbutyloxycarbonyl) king resin
Fmoc-Gly-His (trt)-lys (Boc) Wang Resin: fluorenylmethyloxycarbonyl glycyl histidyl-(trityl) Methionin (tertbutyloxycarbonyl) king resin
Fmoc-Gly-OH: fluorenylmethyloxycarbonyl glycine
H-Gly-His (trt)-lys (Boc) Wang Resin: glycyl histidyl-(trityl) Methionin (tertbutyloxycarbonyl) king resin
H-Gly-His-Lys-OH: glycyl histidyl-Methionin
The invention has the beneficial effects as follows: speed of response of the present invention is fast, pollute little, the productive rate height.Because what adopt is the amino acid of Fmoc system, safer than traditional Boc system, convenient, what adopt when taking off Fmoc is that the DMF solution of 20% hexahydropyridine is more safer than 50% trifluoroacetic acid (TFA), pollutes littler.Polypeptide is to add water to quantitative back to wash with ethyl acetate after resin cuts down.The bad ammonia ester that contains among the GHK is hydrophilic amino acid, is not fine with traditional method of separating out that adds diethyl ether, and the curing of polypeptide in ether is not very desirable, and causes waste easily.The treatment process of present method has been avoided this point, so productive rate is higher.
Embodiment:
Embodiment 1:
1) drop into Fmoc-Lys (Boc)-OH and Wang Resin in the eggplant-shape bottle in proportion; excessive 1.5 times of Methionin; DMF makees solvent; with Fmoc-Lys (Boc)-OH dissolving; add DIC again; HOBT; DMAP is as activator; under 45 ℃~50 ℃ temperature; put into vibrator oscillatory reaction 4h, take out the back and filter with sand core funnel. use DMF; methyl alcohol; methylene dichloride washs resulting resin successively, weighs after drying; calculate the loading value (being the amount of Fmoc-Lys (Boc)-OH contained in every gram resin) of resin, with Fmoc-Lys (the Boc)-OH functional group acetylize that does not have on the Wang Resin to connect.Concrete operations are: above-mentioned resin is dropped in the eggplant-shape bottle; adding the acetylizad liquor capacity proportioning of functional group is: aceticanhydride: methylene dichloride: the solution of pyridine=1: 2: 2; under 45 ℃~50 ℃ temperature, in vibrator, react 2h; taking out the back filters with sand core funnel; use DMF, methylene dichloride, 5% aqueous acetic acid then; methyl alcohol; methylene dichloride washs 2~3 times successively; dry; weigh; the resin that takes a morsel is tested look with the triketohydrindene hydrate developer, if colourless then explanation reacts completely, obtains Fmoc-Lys (Boc) Wang Resin.
2) Fmoc-Lys (Boc) the Wang Resin that obtains in the step 1) is put into connect the peptide bottle, hexahydropyridine-DMF the solution of adding 20%, feed nitrogen reaction 30min, drain reaction solution, with DMF, methyl alcohol, methylene dichloride washing resin successively 2~3 times, the resin that takes a morsel is tested look with the triketohydrindene hydrate developer, and color is dark blue or bluish voilet, product 1 then is described) in Fmoc remove, obtain H-Lys (Boc) Wang Resin.
3) Fmoc-His (trt)-OH is added step 2 is housed) the connecing in the peptide bottle of product, dissolve with DMF, add HBTU (O-Benzotriazole-N, N, N ', N '-tetramethyl-uronium-hexafluorophosphate), the N-methylmorpholine, logical nitrogen reaction 40min, drain reaction solution, with DMF, methyl alcohol, methylene dichloride washing resin successively 2~3 times, the resin that takes a morsel is tested look with the triketohydrindene hydrate developer, color is that colourless then explanation reacts completely, and obtains product Fmoc-His (trt)-Lys (Boc) Wang Resin.
4) with step 2) described, with 20% hexahydropyridine-DMF solution removal Fmoc, to test look be dark blue or hyacinthine then illustrates and reacts completely, and obtains H-His (trt)-Lys (Boc) Wang Resin with resultant product in the step 3).
5) connecing in the peptide bottle of step 4) product is equipped with in the Fmac-Gly-OH adding, dissolve with DMF, add the HBTU.N-methylmorpholine, logical nitrogen reaction 40min, drain reaction solution, with DMF, methyl alcohol, methylene dichloride washing resin successively 2~3 times, the resin that takes a morsel is tested look, color is that colourless then explanation reacts completely, and obtains product Fmoc-Gly-His (trt)-Lys (Boc) Wang Resin.
6) be dark blue with adding 20% hexahydropyridine-DMF solution removal Fmoc in the products therefrom in the step 5), testing look or hyacinthine then illustrates and reacts completely, and obtains H-Gly-His (trt)-Lys (Boc) Wang Resin.
7) products therefrom in the step 6) is put into eggplant-shape bottle, add trifluoroacetic acid (TFA), put into vibrator and react, take out behind the 2h and filter with sand core funnel.In filtrate, add water to quantitatively, filtrate is added in the separating funnel,, at last the filtrate freeze-drying is got the white powder solid, be the finished product with the ethyl acetate washing.
Embodiment 2, and Methionin is excessive 1.7 times in the step 1, and the oscillatory reaction time is 3 hours; The concentration of the DMF solution of hexahydropyridine is 10% in the step 2,4,6, and step 7 duration of oscillation is 1 hour.All the other are identical with embodiment 1.
Embodiment 3, and Methionin is excessive 2 times in the step 1, and the oscillatory reaction time is 5 hours; The concentration of the DMF solution of hexahydropyridine is 30% in the step 2,4,6, and step 7 duration of oscillation is 3 hours.All the other are identical with embodiment 1.
Claims (7)
1. the solid phase synthesis process of a glycyl histidyl-Methionin is characterized in that may further comprise the steps:
A, Methionin and king's resin are mixed in proportion, add I-hydroxybenzotriazole, N, N '-di-isopropyl carbimide and 4-Dimethylamino pyridine are as activator, with N, N '-dimethyl formamide is made solvent 45 ℃~50 ℃ following oscillatory reactions, obtains fluorenylmethyloxycarbonyl Methionin (tertbutyloxycarbonyl) king resin behind the reaction product filtration washing;
B, with fluorenylmethyloxycarbonyl Methionin (tertbutyloxycarbonyl) the king resin that obtains in the step 1, add the N of hexahydropyridine, in N '-dimethyl formamide solution, the fluorenylmethyloxycarbonyl group is removed, obtain Methionin (tertbutyloxycarbonyl) king resin; Add fluorenylmethyloxycarbonyl (trityl) Histidine then, reaction obtains fluorenylmethyloxycarbonyl histidyl-(trityl) Methionin (tertbutyloxycarbonyl) king resin through amidated;
C, the fluorenylmethyloxycarbonyl of fluorenylmethyloxycarbonyl histidyl-(trityl) Methionin (tertbutyloxycarbonyl) the king resin that obtains in the step 2 is removed, add the fluorenylmethyloxycarbonyl glycine, obtain fluorenylmethyloxycarbonyl glycyl histidyl-(trityl) Methionin (tertbutyloxycarbonyl) king resin by the amidated reaction;
D, get the product in the step 3, remove fluorenylmethyloxycarbonyl, add trifluoroacetic acid, the vibration after-filtration is got filtrate washing freeze-drying and can be got glycyl histidyl-Methionin.
2. the solid phase synthesis process of glycyl histidyl-Methionin according to claim 1, Methionin is excessive 1.5~2 times when it is characterized in that among the step a Methionin and king's mixed with resin.
3. the solid phase synthesis process of glycyl histidyl-Methionin according to claim 1 is characterized in that the oscillatory reaction time is 3~5 hours among the step a.
4. the solid phase synthesis process of glycyl histidyl-Methionin according to claim 1, the concentration that it is characterized in that the DMF solution of hexahydropyridine among the step b is 10~30%.
5. the solid phase synthesis process of glycyl histidyl-Methionin according to claim 1 is characterized in that duration of oscillation is 1~3 hour in the steps d.
6. the solid phase synthesis process of glycyl histidyl-Methionin according to claim 1 is characterized in that washing is to use N among the step a, and N '-dimethyl formamide, methylene dichloride, 5% aqueous acetic acid, methyl alcohol wash 2~3 times successively.
7. the solid phase synthesis process of glycyl histidyl-Methionin according to claim 1 is characterized in that the used washings of washing is an ethyl acetate in the steps d.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA200810043144XA CN101230089A (en) | 2008-02-22 | 2008-02-22 | Solid-phase synthesis of glycyl histidyl lycine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA200810043144XA CN101230089A (en) | 2008-02-22 | 2008-02-22 | Solid-phase synthesis of glycyl histidyl lycine |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101230089A true CN101230089A (en) | 2008-07-30 |
Family
ID=39896948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA200810043144XA Pending CN101230089A (en) | 2008-02-22 | 2008-02-22 | Solid-phase synthesis of glycyl histidyl lycine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101230089A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101863960B (en) * | 2009-04-15 | 2013-03-06 | 无锡市凯利药业有限公司 | Preparation method of cetrorelix |
CN103344592A (en) * | 2013-07-18 | 2013-10-09 | 齐鲁工业大学 | Determining method for GHK (Glycyl-L-Histidyl-L-Lysine) content |
CN107098950A (en) * | 2017-06-13 | 2017-08-29 | 湖北泓肽生物科技有限公司 | A kind of synthetic method of GHK or AHK tripeptides |
CN114671912A (en) * | 2022-03-03 | 2022-06-28 | 西北工业大学 | A method for photo-cleavable carrier-assisted homogeneous synthesis of blue copper tripeptide |
-
2008
- 2008-02-22 CN CNA200810043144XA patent/CN101230089A/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101863960B (en) * | 2009-04-15 | 2013-03-06 | 无锡市凯利药业有限公司 | Preparation method of cetrorelix |
CN103344592A (en) * | 2013-07-18 | 2013-10-09 | 齐鲁工业大学 | Determining method for GHK (Glycyl-L-Histidyl-L-Lysine) content |
CN103344592B (en) * | 2013-07-18 | 2015-06-17 | 齐鲁工业大学 | Determining method for GHK (Glycyl-L-Histidyl-L-Lysine) content |
CN107098950A (en) * | 2017-06-13 | 2017-08-29 | 湖北泓肽生物科技有限公司 | A kind of synthetic method of GHK or AHK tripeptides |
CN107098950B (en) * | 2017-06-13 | 2019-11-08 | 湖北泓肽生物科技有限公司 | A kind of synthetic method of GHK or AHK tripeptides |
CN114671912A (en) * | 2022-03-03 | 2022-06-28 | 西北工业大学 | A method for photo-cleavable carrier-assisted homogeneous synthesis of blue copper tripeptide |
CN114671912B (en) * | 2022-03-03 | 2024-05-14 | 西北工业大学 | Method for homogeneously synthesizing blue copper tripeptide with assistance of light shearing carrier |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0406428B1 (en) | Peptide derivatives and their use | |
Hudson et al. | Methionine enkephalin and isosteric analogues I. Synthesis on a phenolic resin support | |
CA1065856A (en) | Derivatives of salmon calcitonin | |
JP2679786B2 (en) | Method for synthesizing peptide having non-peptide bond | |
CN103613642B (en) | Liquid-phase segmented synthesis method of argireline | |
US4107298A (en) | Antigenically active polypeptide and a process for its preparation | |
CN109836455B (en) | Liquid phase synthesis method of thymopentin based on phosphorus or phosphorus acyloxy diphenyl methanol and derivatives thereof and assistance | |
CN103224558B (en) | A kind of preparation method of Exenatide | |
CN101463072B (en) | Preparation of cholecystokinin octapeptide | |
CN110294800A (en) | A kind of preparation method of Suo Malu peptide | |
JPH05170791A (en) | Solid state synthesis of peptide containing c-terminated azaamino acid amide | |
CN101230089A (en) | Solid-phase synthesis of glycyl histidyl lycine | |
JPH0549466A (en) | Reaction tank | |
CN103012565B (en) | Triptorelin and solid-phase synthesis preparation method thereof | |
CN104211801A (en) | Method for preparing lixisenatide | |
Robertson et al. | Racemisation studies of a novel coupling reagent for solid phase peptide synthesis | |
EP0123951A2 (en) | Intermediates for thymosin alpha 1 | |
LENDER et al. | Design and synthesis of sulfur‐free cyclic hexapeptides which contain the RGD sequence and bind to the fibrinogen GP IIb/IIIa receptor: A conformation‐based correlation between propensity for imide formation and receptor affinity | |
CN103641894A (en) | Preparation method of polypeptide medicine for treating cushing disease | |
CN107446025B (en) | Preparation method of alarelin | |
CN110950933A (en) | A kind of solid-liquid phase synthesis method of Bumenotide | |
CN112679600B (en) | Method for preparing thymalfasin by solid-liquid phase combination | |
Zabrocki et al. | The 1, 5-disubstituted tetrazole ring as a cis-amide bond surrogate | |
CN111285921B (en) | BDK auxiliary group and liquid phase total synthesis method of procalcitonin and analog based on BDK auxiliary group | |
CN107417786B (en) | Preparation method of thymosin alpha 1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20080730 |